bf/NASDAQ:TNDM_icon.jpeg

NASDAQ:TNDM

Tandem Diabetes Care, Inc.

  • Stock

USD

Last Close

46.93

17/05 20:00

Market Cap

1.49B

Beta: 0.98

Volume Today

1.11M

Avg: 1.32M

PE Ratio

−7.18

PFCF: −30.88

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
8.30M
-
11.12M
34.07%
14.73M
32.43%
19.37M
31.51%
24.09M
24.39%
23.44M
2.70%
34.48M
47.09%
56.40M
63.54%
66.14M
17.27%
89.83M
35.83%
134.53M
49.75%
average payables
4.08M
-
8.47M
107.48%
16.85M
98.94%
19.22M
14.04%
20.90M
8.73%
28.63M
36.99%
26.26M
8.25%
17.77M
32.32%
22.92M
28.94%
41.88M
82.74%
52.66M
25.73%
average receivables
3.87M
-
6.48M
67.42%
10.85M
67.62%
12.61M
16.22%
15.98M
26.71%
27.99M
75.15%
40.89M
46.07%
64.39M
57.48%
96.46M
49.81%
112.72M
16.86%
110.14M
2.29%
book value per share
392.72
-
23.45
94.03%
21.95
6.41%
-1.94
108.83%
-5.13
164.82%
2.73
153.12%
3.33
22.18%
6.01
80.22%
6.87
14.47%
6.86
0.24%
4.83
29.61%
capex per share
-20.43
-
-1.97
90.37%
-2.02
2.60%
-2.92
44.71%
-1.01
65.52%
-0.06
93.84%
-0.33
438.34%
-0.53
58.53%
-0.37
29.52%
-0.67
79.43%
-0.79
18.62%
capex to depreciation
-1.90
-
-1.04
45.02%
-1.21
15.88%
-1.63
34.57%
-0.83
48.81%
-0.51
38.40%
-3.22
527.37%
-3.09
3.98%
-1.70
45.04%
-3.00
76.51%
-3.28
9.55%
capex to operating cash flow
0.13
-
0.07
40.72%
0.10
33.17%
0.15
46.94%
0.09
40.77%
0.36
315.16%
-0.47
229.92%
-1.31
180.73%
-0.21
83.87%
-0.85
303.14%
1.62
290.59%
capex to revenue
-0.21
-
-0.09
55.55%
-0.08
12.98%
-0.11
32.27%
-0.05
49.87%
-0.02
69.44%
-0.05
232.11%
-0.06
20.03%
-0.03
48.33%
-0.05
60.25%
-0.07
28.74%
cash per share
440.11
-
28.91
93.43%
24.59
14.96%
17.51
28.77%
2.50
85.74%
2.68
7.34%
3.02
12.50%
7.95
163.63%
9.90
24.53%
9.62
2.87%
7.20
25.11%
days of inventory on hand
165.08
-
126.13
23.59%
138.39
9.72%
127.54
7.84%
155.14
21.64%
77.22
50.23%
106.56
37.99%
97.60
8.41%
76.61
21.50%
104.47
36.36%
151.69
45.20%
days payables outstanding
37.59
-
154.48
311.01%
150.80
2.39%
116.29
22.88%
129.14
11.05%
135.00
4.54%
38.53
71.46%
27.27
29.23%
31.33
14.88%
52.40
67.24%
47.63
9.10%
days sales outstanding
66.67
-
56.17
15.75%
70.42
25.36%
48.40
31.27%
70.53
45.72%
69.86
0.95%
46.93
32.82%
60.14
28.15%
57.51
4.39%
52.26
9.12%
51.53
1.40%
debt to assets
0.23
-
0.28
19.57%
0.24
14.25%
0.70
196.27%
0.80
14.27%
0.06
-
0.32
409.89%
0.35
9.08%
0.40
14.72%
0.44
9.40%
debt to equity
0.32
-
0.54
66.14%
0.47
13.35%
-13.32
2,949.86%
-2.63
80.29%
0.10
-
0.62
496.24%
0.73
16.56%
0.95
31.36%
1.33
38.87%
dividend yield
earnings yield
-0.83
-
-0.27
67.69%
-0.21
21.20%
-1.27
498.80%
-5.45
329.35%
-0.07
98.77%
-0.01
89.42%
-0.01
16.99%
0.00
127.86%
-0.03
2,098.58%
-0.12
253.08%
enterprise value
-19.17M
-
293.82M
1,632.44%
328.13M
11.68%
100.01M
69.52%
76.24M
23.77%
1.79B
2,242.16%
3.46B
93.59%
5.97B
72.68%
9.73B
62.94%
3.13B
67.81%
2.28B
27.22%
enterprise value over ebitda
0.41
-
-3.88
1,036.93%
-4.76
22.46%
-1.28
73.05%
-1.21
5.47%
-40.01
3,203.19%
-206.72
416.69%
-750.19
262.90%
429.36
157.23%
-101.75
123.70%
-19.27
81.06%
ev to operating cash flow
0.40
-
-4.79
1,292.35%
-5.58
16.64%
-1.63
70.72%
-1.15
29.49%
-214.65
18,520.15%
82.49
138.43%
241.97
193.33%
87.34
63.90%
62.04
28.97%
-71.63
215.46%
ev to sales
-0.66
-
5.91
993.99%
4.50
23.78%
1.19
73.65%
0.71
40.31%
9.71
1,270.66%
9.54
1.75%
11.97
25.42%
13.84
15.65%
3.91
71.77%
3.05
22.01%
free cash flow per share
-182.75
-
-28.34
84.49%
-22.34
21.18%
-22.93
2.66%
-12.66
44.81%
-0.23
98.14%
0.38
262.73%
-0.13
132.71%
1.39
1,215.35%
0.12
91.60%
-1.28
1,196.33%
free cash flow yield
-0.71
-
-0.22
68.53%
-0.19
15.24%
-1.07
463.90%
-5.36
402.83%
-0.01
99.88%
0.01
203.66%
-0.00
120.38%
0.01
808.99%
0.00
71.88%
-0.04
1,765.99%
graham net net
312.51
-
11.64
96.28%
9.95
14.53%
-14.98
250.63%
-14.31
4.51%
1.88
113.12%
1.79
4.58%
3.74
109.00%
4.27
14.10%
2.27
46.84%
-0.20
108.80%
graham number
1.38K
-
134.27
90.25%
111.20
17.19%
34.51
68.97%
38.55
11.72%
12.50
67.57%
5.63
54.95%
8.73
54.96%
6.18
29.17%
15.09
144.01%
19.29
27.88%
income quality
0.76
-
0.77
2.04%
0.81
5.14%
0.73
9.66%
0.91
23.53%
0.07
92.51%
-1.69
2,595.15%
-0.72
57.62%
7.15
1,097.08%
-0.53
107.46%
0.14
126.79%
intangibles to total assets
0.02
-
0.02
37.90%
0.02
26.45%
0.02
5.88%
0.02
3.73%
0.01
64.15%
0.00
56.50%
0.01
415.83%
0.01
40.35%
0.00
40.05%
0.00
33.70%
interest coverage
-10.50
-
-19.40
84.79%
-18.45
4.90%
-13.68
25.85%
-5.55
59.42%
-5.88
6.03%
-214.38
3,542.97%
-0.65
99.69%
2.04
411.91%
-14.33
801.74%
-30.83
115.13%
interest debt per share
143.52
-
14.33
90.02%
11.55
19.36%
27.70
139.74%
15.48
44.11%
0.16
98.98%
0.35
121.94%
3.94
1,027.42%
5.06
28.42%
6.61
30.61%
6.51
1.49%
inventory turnover
2.21
-
2.89
30.88%
2.64
8.86%
2.86
8.50%
2.35
17.79%
4.73
100.91%
3.43
27.53%
3.74
9.18%
4.76
27.39%
3.49
26.66%
2.41
31.13%
invested capital
0.32
-
0.54
66.14%
0.47
13.35%
-13.32
2,949.86%
-2.63
80.29%
0.10
-
0.62
496.24%
0.73
16.56%
0.95
31.36%
1.33
38.87%
market cap
75.82M
-
295.55M
289.83%
341.55M
15.56%
65.73M
80.76%
13.40M
79.62%
1.83B
13,540.07%
3.49B
90.84%
5.84B
67.32%
9.48B
62.50%
2.88B
69.59%
1.92B
33.35%
net current asset value
102.31M
-
38.86M
62.02%
45.33M
16.66%
-26.23M
157.85%
-60.34M
130.06%
112.87M
287.06%
145.01M
28.48%
287.13M
98.00%
339.50M
18.24%
237.14M
30.15%
108.96M
54.05%
net debt to ebitda
2.05
-
0.02
98.88%
0.19
747.59%
-0.44
325.86%
-1.00
127.30%
0.94
193.87%
1.84
96.49%
-16.80
1,012.54%
10.75
163.97%
-8.04
174.79%
-3.02
62.46%
net income per share
-214.61
-
-34.17
84.08%
-25.04
26.72%
-27.30
9.01%
-12.86
52.87%
-2.55
80.20%
-0.42
83.39%
-0.56
33.25%
0.25
143.83%
-1.47
696.84%
-3.43
132.35%
operating cash flow per share
-162.33
-
-26.37
83.75%
-20.32
22.96%
-20.01
1.52%
-11.65
41.78%
-0.17
98.52%
0.72
514.38%
0.40
43.53%
1.77
337.01%
0.79
55.49%
-0.49
162.24%
payables turnover
9.71
-
2.36
75.67%
2.42
2.45%
3.14
29.67%
2.83
9.95%
2.70
4.34%
9.47
250.37%
13.38
41.29%
11.65
12.96%
6.97
40.21%
7.66
10.02%
receivables turnover
5.47
-
6.50
18.69%
5.18
20.23%
7.54
45.49%
5.17
31.38%
5.22
0.96%
7.78
48.86%
6.07
21.97%
6.35
4.59%
6.98
10.04%
7.08
1.42%
research and ddevelopement to revenue
0.38
-
0.32
16.85%
0.23
26.68%
0.22
4.12%
0.19
13.99%
0.16
17.22%
0.12
21.52%
0.13
2.16%
0.13
2.77%
0.17
32.56%
0.23
30.69%
return on tangible assets
-0.40
-
-0.76
93.14%
-0.59
22.99%
-0.75
28.15%
-0.78
3.11%
-0.60
23.17%
-0.08
87.27%
-0.05
36.14%
0.02
135.66%
-0.09
620.93%
-0.23
159.68%
revenue per share
98.59
-
21.37
78.33%
25.19
17.90%
27.56
9.40%
18.95
31.22%
3.82
79.84%
6.19
62.10%
8.18
32.08%
11.16
36.39%
12.49
11.97%
11.51
7.86%
roe
-0.55
-
-1.46
166.66%
-1.14
21.70%
14.08
1,333.91%
2.51
82.20%
-0.93
137.28%
-0.13
86.41%
-0.09
26.07%
0.04
138.29%
-0.22
698.26%
-0.71
230.11%
roic
-0.35
-
-0.90
159.72%
-0.74
17.80%
-1.07
44.20%
-1.33
24.31%
-0.34
74.39%
-0.07
79.02%
-0.01
82.96%
0.01
190.77%
-0.06
672.36%
-0.27
333.79%
sales general and administrative to revenue
1.51
-
1.08
28.57%
0.98
8.90%
0.80
18.35%
shareholders equity per share
392.72
-
23.45
94.03%
21.95
6.41%
-1.94
108.83%
-5.13
164.82%
2.73
153.12%
3.33
22.18%
6.01
80.22%
6.87
14.47%
6.86
0.24%
4.83
29.61%
stock based compensation to revenue
0.15
-
0.30
96.29%
0.18
40.39%
0.14
23.01%
0.12
15.20%
0.13
10.00%
0.16
24.16%
0.12
26.92%
0.09
26.20%
0.11
22.61%
0.12
11.14%
tangible asset value
112.84M
-
52.13M
53.80%
61.36M
17.70%
-7.71M
112.57%
-30.61M
296.90%
130.15M
525.24%
194.20M
49.22%
357.50M
84.09%
426.48M
19.29%
435.32M
2.07%
310.86M
28.59%
tangible book value per share
383.55
-
22.40
94.16%
21.22
5.29%
-2.52
111.89%
-5.39
113.73%
2.70
150.16%
3.32
22.75%
5.86
76.59%
6.77
15.49%
6.79
0.25%
4.78
29.50%
working capital
134.39M
-
72.66M
45.94%
80.46M
10.75%
60.62M
24.67%
28.07M
53.69%
121.60M
333.18%
176.75M
45.35%
533.38M
201.78%
679.66M
27.43%
684.69M
0.74%
552.73M
19.27%

All numbers in USD (except ratios and percentages)